Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency

Context. Transient secondary adrenal insufficiency (SAI) is an expected complication following successful adenomectomy of ACTH-secreting pituitary adenomas or unilateral adrenalectomy for cortisol-secreting adrenal adenomas. To date, no pharmacological therapy has been shown to hasten recovery of th...

Full description

Saved in:
Bibliographic Details
Main Author: Pejman Cohan
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/4709597
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556721048911872
author Pejman Cohan
author_facet Pejman Cohan
author_sort Pejman Cohan
collection DOAJ
description Context. Transient secondary adrenal insufficiency (SAI) is an expected complication following successful adenomectomy of ACTH-secreting pituitary adenomas or unilateral adrenalectomy for cortisol-secreting adrenal adenomas. To date, no pharmacological therapy has been shown to hasten recovery of the hypothalamic-pituitary-adrenal (HPA) axis in this clinical scenario. Case Description. A 33-year-old woman underwent uncomplicated unilateral adrenalectomy for a 3.7 cm cortisol-secreting adrenal adenoma. Postoperatively, she developed SAI and was placed on hydrocortisone 15 mg/day, given in divided doses. In the ensuing six years, the patient’s HPA axis failed to recover and she remained corticosteroid-dependent. Quarterly biochemical testing (after withholding hydrocortisone for 18 hours) consistently yielded undetectable serum cortisol and subnormal plasma ACTH levels. While she was on hydrocortisone 15 mg/day, mifepristone was initiated and gradually titrated to a maintenance dose of 600 mg/day after 5 months. Rapid recovery of the HPA axis was subsequently noted with ACTH rising into the supranormal range at 4 months followed by a subsequent rise in cortisol levels into the normal range. After 6 months, the dose of hydrocortisone and mifepristone was lowered and both were ultimately stopped after 8 months. The HPA axis remains normal after an additional 16 months of follow-up. Conclusion. Mifepristone successfully restored the HPA axis in a woman with prolonged secondary adrenal insufficiency (SAI) after adrenalectomy for Cushing’s syndrome (CS).
format Article
id doaj-art-fb14c97652d5428c88844d9d208cbc1a
institution Kabale University
issn 2090-6501
2090-651X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-fb14c97652d5428c88844d9d208cbc1a2025-02-03T05:44:40ZengWileyCase Reports in Endocrinology2090-65012090-651X2016-01-01201610.1155/2016/47095974709597Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal InsufficiencyPejman Cohan0Specialized Endocrine Care Center, 150 North Robertson Boulevard, Suite 210, Beverly Hills, CA 90211, USAContext. Transient secondary adrenal insufficiency (SAI) is an expected complication following successful adenomectomy of ACTH-secreting pituitary adenomas or unilateral adrenalectomy for cortisol-secreting adrenal adenomas. To date, no pharmacological therapy has been shown to hasten recovery of the hypothalamic-pituitary-adrenal (HPA) axis in this clinical scenario. Case Description. A 33-year-old woman underwent uncomplicated unilateral adrenalectomy for a 3.7 cm cortisol-secreting adrenal adenoma. Postoperatively, she developed SAI and was placed on hydrocortisone 15 mg/day, given in divided doses. In the ensuing six years, the patient’s HPA axis failed to recover and she remained corticosteroid-dependent. Quarterly biochemical testing (after withholding hydrocortisone for 18 hours) consistently yielded undetectable serum cortisol and subnormal plasma ACTH levels. While she was on hydrocortisone 15 mg/day, mifepristone was initiated and gradually titrated to a maintenance dose of 600 mg/day after 5 months. Rapid recovery of the HPA axis was subsequently noted with ACTH rising into the supranormal range at 4 months followed by a subsequent rise in cortisol levels into the normal range. After 6 months, the dose of hydrocortisone and mifepristone was lowered and both were ultimately stopped after 8 months. The HPA axis remains normal after an additional 16 months of follow-up. Conclusion. Mifepristone successfully restored the HPA axis in a woman with prolonged secondary adrenal insufficiency (SAI) after adrenalectomy for Cushing’s syndrome (CS).http://dx.doi.org/10.1155/2016/4709597
spellingShingle Pejman Cohan
Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
Case Reports in Endocrinology
title Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
title_full Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
title_fullStr Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
title_full_unstemmed Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
title_short Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
title_sort mifepristone accelerates hpa axis recovery in secondary adrenal insufficiency
url http://dx.doi.org/10.1155/2016/4709597
work_keys_str_mv AT pejmancohan mifepristoneaccelerateshpaaxisrecoveryinsecondaryadrenalinsufficiency